Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Hepatitis Treatment Market

Hepatitis Treatment Market Share

Report ID: GMI10910
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Hepatitis Treatment Market Share

The market is driven by continuous innovation and technological advancements. Leading companies offer a wide range of advanced hepatitis treatments, including medications, along with strategic initiatives to sustain market competition. These companies are continually investing in research and development to introduce new products and enhance existing ones.

Hepatitis Treatment Market Companies

Prominent players operating in the market include:

Service Providers
- Barnes-Jewish Hospital
- Bumrungrad International Hospital
- Cedars-Sinai
- Cleveland Clinic
- Mayo Clinic
Medication Manufacturers
- AbbVie Inc.
- Biocon, Inc.
- Bristol-Myers Squibb Company
- Dynavax Technologies
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmith Kline plc
- Lupin Limited
- Merck & Co., Inc.
- Novartis AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The hepatitis treatment industry size was USD 22.2 billion in 2023 and is projected to grow at a 3.5% CAGR due to the rising incidence of hepatitis B and C viruses and the greater global awareness of these conditions.

The hepatitis treatment industry from the hepatitis C segment recorded USD 9.8 billion in 2023, driven by rising infection rates and advancements in anti-viral treatments.

North America hepatitis treatment market will expand at a 3.7% CAGR through 2032, supported by the prevalence of hepatitis B and C, advancements in antiviral therapies, a strong healthcare infrastructure, and enhanced awareness and screening programs.

Barnes-Jewish Hospital, Bumrungrad International Hospital, Cedars-Sinai, Cleveland Clinic, Mayo Clinic, AbbVie Inc., Biocon, Inc., Bristol-Myers Squibb Company, Dynavax Technologies, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmith Kline plc, Lupin Limited, Merck & Co., Inc., and Novartis AG.